Skip to main content
. 2021 Aug 23;9:688855. doi: 10.3389/fcell.2021.688855

FIGURE 2.

FIGURE 2

Differentially expressed lncRNAs in cisplatin-treated HeLa cells. (A) Heatmap of top 1,000 differentially expressed transcripts in cisplatin- and DMSO-treated HeLa cells. HeLa cells were treated with cisplatin as explained in Figure 1B. (B) qPCR analyses of candidate lncRNAs. qPCR was carried out with total RNAs isolated from control (0.1% DMSO) and cisplatin-treated HeLa cells. Relative expression of candidate genes was normalized against GAPDH. ∗∗∗p ≤ 0.001, ****p ≤ 0.0001.

HHS Vulnerability Disclosure